Key result
LVA ablation in paroxysmal AF leads to ~5-fold higher risk of long-term HF hospitalization.
Why the study?
Extensive left atrial ablation may impair atrial function, and the long-term impact of low-voltage area ablation on heart failure development in patients with paroxysmal atrial fibrillation remained unclear.
Does additional low-voltage area (LVA) ablation affect the long-term risk of heart failure hospitalization in patients with paroxysmal atrial fibrillation undergoing first-time catheter ablation?
RCT (n=398)
Randomized controlled (VOLCANO trial)
Does additional low-voltage area (LVA) ablation affect the long-term risk of heart failure hospitalization in patients with paroxysmal atrial fibrillation undergoing first-time catheter ablation?
Additional low-voltage area ablation in patients with paroxysmal atrial fibrillation is associated with a significantly higher risk of long-term heart failure hospitalization, suggesting that extensive atrial substrate modification may adversely affect heart failure prognosis.
Answers are grounded in this paper and cite their sources.
LVA ablation increases long-term HF hospitalization in paroxysmal AF; challenges routine substrate modification and warrants clinical caution.
Background Extensive left atrial ablation may impair atrial function; however, its long-term impact on the risk of heart failure (HF) development remains unclear. Purpose This study aimed to evaluate the long-term effect of low-voltage area (LVA) ablation on HF outcomes using extended follow-up data from the randomized controlled VOLCANO trial, which assessed the rhythm efficacy of LVA ablation in patients with paroxysmal atrial fibrillation (PAF). Methods This analysis included 404 patients who underwent first-time catheter ablation for PAF in the VOLCANO trial and were followed for HF hospitalization for up to 7 years. Patients were categorized into three groups: Group A, no LVA (n = 336); Group B, LVA with ablation (n = 30); and Group C, LVA without ablation (n = 32). Patients with incomplete voltage mapping were excluded from the comparative analyses. Results Among 398 patients (median age, 71 [63–77] years; 56% male), 25 experienced HF hospitalization and 20 died during a median follow-up of 1,524 (732–2,594) days. The incidence of HF hospitalization differed significantly among the three groups (P < 0.001; Figure). Notably, HF hospitalization occurred more frequently in Group B than in Group C (30.0% vs. 9.3%, P = 0.032). In multivariable analysis adjusted for baseline clinical variables, LVA ablation was independently associated with an increased risk of HF hospitalization (adjusted hazard ratio, 5.03; 95% confidence interval, 1.10–25.3; P = 0.04). Conclusions In patients with PAF and LVA, additional LVA ablation was associated with a significantly higher risk of long-term HF hospitalization. These findings suggest that extensive atrial substrate modification may adversely affect HF prognosis.HF_hospitalizaton_curve.jpg
No takes yet. Share an insight, caveat, or question.
Ochi et al. (2026) conducted an RCT in Paroxysmal atrial fibrillation (n=398). Low-voltage area (LVA) ablation vs. LVA without ablation (and no LVA) was evaluated on Heart failure (HF) hospitalization (adjusted HR 5.03, 95% CI 1.10-25.3, p=0.04). Low-voltage area ablation in paroxysmal AF increased long-term HF hospitalization vs no LVA ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: